Personality can be thought of as a set of characteristics that influence people's thoughts, feelings and behavior across a variety of settings. Variation in personality is predictive of many outcomes in life, including mental health. Here we report on a meta-analysis of genome-wide association (GWA) data for personality in 10 discovery samples (17 375 adults) and five in silico replication samples (3294 adults). All participants were of European ancestry. Personality scores for Neuroticism, Extraversion, Openness to Experience, Agreeableness and Conscientiousness were based on the NEO Five-Factor Inventory. Genotype data of B2.4M single-nucleotide polymorphisms (SNPs; directly typed and imputed using HapMap data) were available. In the discovery samples, classical association analyses were performed under an additive model followed by meta-analysis using the weighted inverse variance method. Results showed genome-wide significance for Openness to Experience near the RASA1 gene on 5q14.3 (rs1477268 and rs2032794, P = 2.8 Â 10 À8 and 3.1 Â 10
Introduction
The structure of human personality has traditionally been accounted for by a relatively small set of traits. Over the last century, scientific consensus has converged on a taxonomic model of personality traits based on five higher-order dimensions of Neuroticism, Extraversion, Openness to Experience, Agreeableness and Conscientiousness, known as the FiveFactor Model (FFM). 1 These five dimensions are largely independent and provide a broad description of personality. Neuroticism is commonly defined as emotional instability; it involves the experience of negative emotions such as anxiety, depression, hostility and the vulnerability to stress. Extraversion is characterized by positive emotions, gregariousness and the tendency to be active, seek out stimulation and enjoy the company of others. Openness to Experience involves active imagination, aesthetic attentiveness, variety preference and intellectual curiosity. Agreeableness can be defined as the tendency to be cooperative and compassionate rather than suspicious and antagonistic towards others. Lastly, the dimension of Conscientiousness reflects self-discipline, carefulness, thoroughness, organization, deliberation and achievement.
Personality traits predict a host of social, behavioral and health outcomes, such as job performance, longevity and many psychiatric disorders, including substance abuse and dependency, mood disorders such as major depressive disorder (MDD), anxiety disorders and personality disorders. [2] [3] [4] [5] [6] [7] For example, Neuroticism reflects a liability trait for MDD and other mood and anxiety disorders and also explains part of the comorbidity among these disorders. 3, 6, 8, 9 MDD is also predicted by low Conscientiousness. 10, 11 With regard to substance (ab)use, tobacco smokers score high on Neuroticism and low on Conscientiousness. 12, 13 A similar but more extreme pattern is seen for cocaine and heroin users; in contrast, marijuana users score high on Openness to Experience and low on Agreeableness and Conscientiousness. 13 The FFM dimensions further predict tendencies toward different types of personality disorder, with high scores on Neuroticism and low scores on Agreeableness predicting many of the personality disorders and with low or high scores on Extraversion predicting different disorders. 2, 14 Personality is also predictive of beneficial outcomes. High Conscientiousness predicts better performance in the workplace 10, 13, 15 and high Extraversion larger participation in regular leisure time exercise. 16, 17 Twin, adoption and family studies have convincingly shown that each of the FFM personality dimensions is heritable, with heritability estimates ranging between 33 and 65%. [18] [19] [20] [21] Lower-order facets that underlie personality dimensions are genetically correlated, 22 confirming the notion that the higherorder personality dimensions are to a large extent genetically homogeneous. Importantly, genetic influences on personality partly overlap with the genetic factors that influence psychiatric disorders. 3, 6, 10, 20 Thus, gene-finding efforts for the major personality dimensions may yield important insights into the genetic etiology of psychiatric disease.
Gene-finding studies for personality, including genome-wide linkage and association studies, have largely focused on Neuroticism, as measured by the Eysenck Personality Questionnaire or as part of the FFM. [23] [24] [25] [26] [27] [28] [29] [30] [31] Few studies have also included other traits such as Extraversion. 27, 31 The study by Terracciano et al. 31 is to date the only genome-wide association (GWA) study conducted for all five FFM personality dimensions. This study was performed in an isolated sample of 3972 Sardinians, analyzing B362K singlenucleotide polymorphisms (SNPs). Although none of the observed signals reached genome-wide significance (lowest P-value 9.4 Â 10 À7 ), several of the top signals were found in genes that are thought to affect behavioral traits and mental disorders through differential brain functioning (for example, SNAP25 for Neuroticism, CDH13 for Extraversion and CLOCK for Agreeableness).
The aim of the current meta-analytic study was to identify novel genetic variants associated with the FFM personality dimensions by combining GWA study results from 10 studies, including 17 375 individuals of European ancestry from Europe, the United States and Australia. In silico replication of the genome-wide significant SNPs was sought in five additional samples consisting of 3294 individuals.
Materials and methods

Discovery samples
The samples included in the discovery stage of this study are described below. Approval by local institutional review boards was obtained in all studies and written informed consent was given.
SardiNIA-Italy. The SardiNIA study includes 6148 related individuals from four towns in the Ogliastra province of Sardinia, Italy. 21 These individuals represent 62% of the population in these towns. Valid Revised NEO Personality Inventory (NEO-PI-R) 1 personality data were available for 5669 individuals, of which 3972 were genotyped (56.7% women). The mean age of all participants was 42.8 years (s.d. = 17). The mean age of the men was 43.0 years (s.d. = 18) and of the women 42.4 years (s.d. = 17). The sample has been described in more detail by Terracciano and co-workers. 31 NTR/NESDA-the Netherlands. The Netherlands Twin Registry-Netherlands Study of Depression and Anxiety (NTR/NESDA) study consists of unrelated individuals from Dutch twin families registered at the NTR 32 and participants from the NESDA. 33 Individuals were selected to be genotyped as part of the Genetic Association Information Network initiative, 34 of which 1836 served as controls (mainly from NTR) and 1862 as cases (mainly from NESDA) in a GWA study for MDD. 35, 36 Controls were selected for the absence of an MDD diagnosis and/or a low genetic liability for MDD. In this study, 3540 individuals (65.6% women) were included with valid NEO personality and GWA data. The mean age of participants was 44.1 years (s.d. = 13). Men were slightly older (M = 46.6 years; s.d. = 13) than women (M = 42.8 years; s.d. = 13). Personality data from NTR participants were collected in 2004 37 and from NESDA participants between 2004 and 2007. 33 ERF-the Netherlands. The Erasmus Rucphen Family (ERF) study is a family-based study including over 3000 individuals from an isolated population in the South-West region of the Netherlands. 38 There were 2400 individuals for whom both NEO personality and GWA data were available. The mean age of all participants was 49 [40] [41] [42] NAG/IRPG study-Australia. Phenotype data from this study was collected as part of the Nicotine Addiction Genetics study (NAG), for which families were targeted based on heavy smoking index cases identified in previous interviews and questionnaires. 43, 44 Personality items, from the NEO-FFI, were included in a questionnaire mailed to all participants. QIMR study-Australia. Data from Australian adolescents were collected in twin family studies conducted at the Queensland Institute of Medical Research (QIMR). Participants were mainly recruited through primary and secondary schools in Queensland for studies of melanocytic naevi (moles). 45 NEO personality data (NEO-PI-R or NEO-FFI) were collected as part of the cognition study (in-person testing, 1996-ongoing), 46 as well as a health and well-being study (a mail/phone study [2002] [2003] , 46 and a study of borderline personality disorder (online/paper survey [2004] [2005] [2006] . 47 For this study, personality and genotypic data were available for 1090 individuals (616 women), of whom 254 were monozygotic twin pairs (for whom average phenotypic data were analyzed). Participants ranged in age from 16 LBC1936-United Kingdom. The Lothian Birth Cohort (LBC) study consists of a cohort of 1091 individuals born in 1936 (LBC1936). Most subjects lived independently in the Lothian region (Edinburgh city and surrounding area) of Scotland. The majority of subjects took part in the Scottish Mental Surveys of 1947, and were assessed again on cognition and medical traits at roughly 70 years of age. 48 A fuller description about participant recruitment and testing can be found elsewhere. 48, 49 There were 888 subjects (447 women) who successfully filled in the NEO-FFI and survived the DNA and genotyping quality control procedures. The mean age of these 888 subjects was 69.6 (s.d. = 1). The mean ages of the men and women were the same.
Baltimore Longitudinal Study of Aging-United States of America. The Baltimore Longitudinal Study of Aging is an ongoing multidisciplinary study of community-dwelling volunteers. Personality traits were assessed from 1989 to 2008, and multiple assessments were available for most participants. Although personality traits are generally stable over time, 50, 51 to provide more robust estimates, we used the average across all available assessments. For this study, we examined data from 848 subjects of European descent that were successfully genotyped and completed the NEO-PI-R questionnaire at least once. In this sample, mean age was 68. EGPUT-Estonia. The Estonian cohort comes from the population-based biobank of the Estonian Genome Project of University of Tartu (EGPUT). The project is conducted according to the Estonian Gene Research Act and all participants have signed the broad informed consent (www.geenivaramu.ee). 52 In total, 38 000 individuals aged 18 years or older participated in this cohort (33% men, 67% women). The population distributions of the cohort reflect those of the Estonian population (83% Estonians, 14% Russians and 3% other). Subjects were randomly recruited by the general practitioners (GP) and physicians in the hospitals. 53 A Computer-Assisted Personal interview was conducted during 1-2 h at doctors' offices. Data on demographics, genealogy, educational and occupational history, lifestyle and anthropometric and physiological data were assessed. For this study, GWA was performed on 600 randomly selected subjects with both Illumina HumanCNV370 genotype (array according to Illumina protocol (www.illumina.com) in Estonian Biocenter Genotyping Core Facility) and the NEO-PI-3 questionnaire data available. 54 In this sample, the age range was 18-87 years (mean 45. 
Replication samples
The samples for in silico replication are described below. In total, the sample size was 3294 subjects.
NTR þ -the Netherlands. Within the Netherlands Twin Register (NTR), several genotyping projects (additional to the first genome-wide genotyping study that was part of the Genetic Association Information Network-MDD study) have been undertaken whose data were combined in this study to form the replication set. All individuals came from the NTR-Biobank study. 55 In total, 1920 individuals with valid NEO-FFI and GWA data were available for replication. The mean age of participants was 46.9 years (s.d. = 15) and 67% were women. This sample included 127 MZ twin pairs (254 twins) with phenotype data in both twins. Those twin pairs were treated as one case in the analysis by averaging their phenotypic scores, resulting in a sample with 1793 subjects for analysis. For 1475 subjects, GWA data were available on one SNP chip; for 318 subjects, GWA data were assessed on two chips. For the majority of the 1475 subjects genotyped on one chip (N = 1286; 87%), genotyping was part of the NTR2 genotyping study using the Illumina Human660W-Quad chip. These subjects were unrelated and unselected for any phenotype. The remaining subjects were genotyped as part of the GenomEUtwin study (N = 137 subjects; Illumina 370K chip), an Attention Deficit Hyperactivity Disorder study (N = 34 subjects; Affymetrix 6.0) and the MDD2000 study (N = 18 MDD cases; Illumina 907K chip). Quality control of genotype data and subsequent imputation using IMPUTE software was conducted on separate sets, and on the full set of all genotyped individuals within the NTR. For the purposes of this replication study, after imputation we selected the SNPs from the discovery set that showed genome-wide significance, checked their quality and subsequently analyzed the SNPs.
Germany. In this German cohort, 2420 healthy control participants were randomly selected from the general population of Munich, Germany, and contacted by mail. We included 476 individuals (56% women) with GWA data (Illumina HumanHap300 chip) in this study. Several screenings were conducted before the volunteers were enrolled in the study. First, subjects who responded were initially screened by phone for the absence of neuropsychiatric disorders. Second, detailed medical and psychiatric histories were assessed for the participants and their first-degree relatives by using a semistructured interview. 56 Third, if no exclusion criteria were fulfilled, they were invited to a comprehensive interview including the SCID to validate the absence of any lifetime psychotic disorder. 57 In addition, the Family History Assessment Module was conducted to exclude psychotic disorders among their first-degree relatives. A neurological examination was also conducted to exclude subjects with current central nervous system impairment. If participants were older than 60 years, the Mini-Mental Status Test was performed to exclude subjects with possible cognitive impairment. 58 Only participants with German descent (all four grandparents German) were included. Furthermore, a large battery of personality questionnaires, for example, on aggression, impulsivity or neuroticism (NEO-PI-R) was obtained as well as data on life events and traumatic events. The mean age of the sample was 46 years (s.d. = 15).
EGPUT2-Estonia. In the Estonian cohort, additional data of 380 individuals with valid NEO-FFI and GWA data have become available for replication. For a more detailed description of this cohort, see the description above for EGPUT. The mean age of participants was 38.9 years (s.d. = 15). Almost half of the sample (49.5%) was female.
Cilento-Italy. The Cilento study is a populationbased study that includes 2137 individuals from three isolated populations of South Italy. Of these individuals, 859 were genotyped on the 370K SNP map from Illumina. Imputation of 2.5M HapMap SNPs was obtained using MACH software. Genome-wide significant SNPs were selected, checked and analyzed. Data available from the NEO-PI-R questionnaire were available for 343 genotyped subjects representing the final sample. Of this sample, 65.6% were women. The mean age of all participants was 58.9 years (s.d. = 19), of the men 59.5 years (s.d. = 18.8) and of the women 58.7 years (s.d. = 19).
ERF2-The Netherlands. The ERF2 sample consisted of 302 additionally genotyped individuals with NEO personality data within the family-based ERF study (see the description above for more information on this study). The mean age of these individuals was 50.1 years (s.d. = 14). Women constituted 50.3% of the sample.
Personality assessment
Personality scores for the five factors Neuroticism, Extraversion, Openness to Experience, Agreeableness and Conscientiousness were based on the 60 items of the NEO-FFI (12 items per factor). 1 Items were answered on a 5-point Likert-type scale ranging from strongly disagree (0) to strongly agree (4). In the SardiNIA, BSLA, Germany and Cilento studies, these items were taken from the 240-item NEO-PI-R. 1 In the QIMR study, the 60 items were taken from the 240-item NEO-PI-R for part of the sample; the remaining subjects filled in the 60-item NEO-FFI. 1 In the NTR, NESDA, ERF, SAGE, HBCS, NAG/IRPG and LBC1936 studies, personality was assessed using the 60-item NEO-FFI. In the Estonian study samples, the 60 NEO-FFI items 59 were taken from the NEO-PI-3.
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In each study, summed scores were computed for all five personality dimensions (after reversing negatively keyed items). If more than three items were missing per dimension, the summed score for that dimension was not computed. If three or less items were missing, missing data were imputed by taking the individual's average score for the valid items of that dimension. The mean scores of the five personality dimensions in each study are provided in Table 1 .
Genotyping and imputation DNA was extracted from blood samples in all participating studies. A detailed overview of SNP genotyping, including the platforms used and subsequent quality control, is given in Table 2 . The studies used Illumina platforms, except for SardiNIA and NTR/NESDA, which used Affymetrix and Perlegen platforms, respectively. Genotype data were To compare results at the SNP level, we imputed B2.5M common SNPs included in HapMap, using the HapMap phase II CEU data as the reference sample. Most studies used NCBI build 36 (UCSC hg18), although in the NTR/NESDA study build 35 (UCSC hg17) was used. Imputation was carried out using IMPUTE for the NTR/NESDA, SAGE and EGPUT samples (consisting of unrelated individuals). 61 For all other samples, genotype data were imputed using MACH software. For those studies that contained related individuals, a maximum likelihood approach was used that takes advantage of the relatedness among individuals. 62 Throughout this paper, the location of SNPs reported is taken from the build 36 (release 22) HapMap data.
Statistical analyses
GWA analysis in each discovery sample. GWA analyses were conducted in each study independently using linear regression (under an additive model) and including sex and age as covariates. For those studies that used IMPUTE software to impute missing genotype data, association analyses were conducted in SNPTEST, taking the uncertainty of the imputed genotypes into account. 61 For the studies that used MACH to impute their data, either MACH QTL or Merlin was used for association analyses. For the three studies with related individuals (SardiNIA, ERF and QIMR), association analyses were performed in Merlin using a variance components approach, which takes into account the relatedness among individuals in these samples. 62 Meta-analysis of GWA results across discovery samples. A meta-analysis of the results was conducted using the weighted inverse variance method in METAL (http://www.sph.umich.edu/csg/ abecasis/metal/index.html), 63 which computes a pooled effect estimate (ln(beta)), its standard error and its P-value by weighing the effect estimates of the individual samples by the inverse of its variance and by taking into account the direction of effect. Poorly imputed SNPs (r 2 or proper_info < 0.30) and SNPs with low MAF ( < 0.01) were excluded, resulting in a final data set of B2.4M SNPs. We corrected for any population stratification effects by applying genomic control in each sample before meta-analysis. The genomic control inflation factors (l) for the five personality dimensions for all participating studies ranged between 0.99 and 1.12 (Supplementary Table 1 ). After applying a genomic control correction to the results from the individual studies, the l's for the meta-analyzed results were 1.02, 1.01, 1.03, 1.00 and 1.02, respectively, for Neuroticism, Extraversion, Openness to Experience, Agreeableness and Conscientiousness. The corresponding Quantile-Quantile plots are provided in Supplementary Figure 1 . To consider an SNP result genome-wide significant, we used the threshold of P < 5 Â 10 À8 per trait as proposed for populations of European descent. 64 Gene-based tests. In addition to the meta-analytic association testing per SNP, we also evaluated the significance of all genes across the genome. We followed the procedure proposed by Liu et al. 65 and incorporated in the program VEGAS, which is suitable for meta-analysis results because it does not require raw genotype data, but instead uses the P-values of SNPs as input. Gene-based P-values were obtained by using a maximum of 10 7 simulations to correctly account for the linkage disequilibrium structure among SNPs within a gene. We included SNPs located up to 20 kb down-or upstream of a gene. A gene was considered genome-wide significant if a P < 2.5 Â 10 À6 (0.05/20 000) was obtained.
Replication analyses. Replication of the SNPs that turned out genome-wide significant was performed in five independent samples. In each sample, an additive test was conducted, with sex and age as covariates. SNPs in each sample were checked for MAF, Hardy-Weinberg equilibrium and if imputed, for imputation quality. The evidence for replication was summarized across samples by conducting a weighted inverse variance meta-analysis. A P < 0.05 was taken as significant evidence of replication.
Results
Two SNPs for Openness to Experience on chromosome 5q14.3 and one SNP for Conscientiousness on chromosome 18q21.1 passed the genome-wide significance level of P < 5 Â 10 À8 in the discovery stage ( Table 3 ). The genome-wide meta-analyzed association results for the five personality dimensions are given in Supplementary Figure 2 . Top SNPs for Neuroticism, Extraversion and Agreeableness (Supplementary Tables 2-6 ) did not reach genomewide significance (lowest P value > 10
À8
). The two genome-wide significant SNPs for Openness to Experience (rs1477268, rs2032794, r 2 among SNPs ranges between 0.92 and 1 across studies) are located on chromosome 5q14.3 in an intergenic region 135 kb downstream from the RASA1 gene (lowest P = 2.8 Â 10
, with an explained variance of 0.22%) (Figure 1a) . The gene-based P-value for RASA1 was 0.02. RASA1 codes for a GTPase-activating protein involved in intracellular signaling and cellular proliferation and differentiation. The gene is highly expressed in the bone marrow and bone, and modestly in the brain. 66 Further, Figure 2a shows that the effect for rs1477268 is in the same direction for nine of the 10 studies. Heterogeneity in results across studies was not significant (w 2 = 9.15, df = 9, P = 0.42). The SNP was genotyped in seven of the studies and imputed with high quality in the SardiNIA, NTR/NESDA and ERF studies (r 2 or proper_info > 0.97). The MAFs were very similar across studies and ranged between 0.15 and 0.24. Furthermore, genotype and allele proportions of rs1477268 are in Hardy-Weinberg equilibrium in all studies (P > 0.01). The association of these two SNPs with Openness to Experience could not, however, be replicated (combined P across the replication samples 0.53 and 0.55, respectively, for rs1477268 and rs2032794, combined P across discovery and replication samples 1.84 Â 10 À6 and 1.70 Â 10
À6
). Tables 4 and 6 ).
The genome-wide significant SNP for Conscientiousness (rs2576037) is located in an intron of the KATNAL2 gene on chromosome 18q21.1 (P = 4.9 Â 10
À8
, explained variance 0.21%). The second-most significant SNP for Conscientiousness (rs7233515) is a non-synonymous SNP in the same gene (lowest P = 7.9 Â 10 À8 , the r 2 with rs2576037 ranges between 0.92 and 1 across studies; Figure 1b) . Variation in this SNP leads to a N88S amino-acid change, suggesting a biologically relevant variation. In eight studies, the direction of the effect for rs2576037 was the same (Figure 2b ). In spite of this, there was nominal significant heterogeneity in the regression coefficients across studies (w 2 = 17.98, df = 9, P = 0.04). To test which study caused the observed heterogeneity, we reran the meta-analysis multiple times, by each time excluding one of the individual studies. Two studies seemed to account for the heterogeneity. Excluding the Finnish HBCS study (with the largest effect), heterogeneity was no longer significant (w 2 = 11.30, df = 8, P = 0.19) and the pooled P-value became 4.3 Â 10
À6
. When excluding the NAG/IRPG study (a small opposite effect), heterogeneity was also no longer observed (w 2 = 11.20, df = 8, P = 0.19) and the pooled P-value became 2.2 Â 10
À9
. The SNP was genotyped in seven of the studies and imputed with high quality in the SardiNIA, NTR/NESDA and ERF studies (r 2 or proper_info > 0.98). The MAFs were very similar across studies and ranged between 0.37 and 0.46 and distributions were in Hardy-Weinberg equilibrium in all studies (P > 0.01).
KATNAL2 encodes a protein similar to the A subunit of the p60 katanin protein and is widely expressed in the central nervous system. 66 Katanin p60 acts to sever microtubules in the axons of neurons and is thought to play a role in neuronal migration, axonal growth and dendritic pruning. [67] [68] [69] Thus, the KATNAL2 gene may play a role in neurodevelopment. Several other SNPs located in the nearby PIAS2, HDHD2 and IER3IP1 genes that are in relatively high linkage disequilibrium (r 2 > 0.5) with the top SNP showed suggestive evidence for association (P < 1 Â 10 À5 ) (Figure 1b and Supplementary Table  6 ). The PIAS2 gene is involved in the regulation of transcription factors involved in the mitogen-activated protein kinase signaling pathway. Less is known about the biological function of the HDHD2 and IER3IP1 genes, but all three genes are moderately expressed in the brain.
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KATNAL2 was significant in gene-based tests as well (Table 3 and Supplementary Table 7 ). The cluster of small TCEB3 genes, located within the KATNAL2 gene (Figure 1b) , was also significant, but the other genes in the region were not genome-wide significant. This suggests that the causal variant may be located in or very near the KATNAL2 gene rather than in any of the surrounding genes. The association of rs2576037 was again not significant in the replication stage (combined P across replication samples = 0.36), although the direction of effect was consistent with the effect found in the discovery stage (Supplementary Table 8 ). The combined P-value across all discovery and replication samples for rs2576037 was 1.02 Â 10
À7
. We also investigated the significance of SNPs that have previously been reported in the first GWA study for the FFM personality traits (Supplementary Table  9 ) and in the two GWA studies for Neuroticism (Supplementary Table 10) . 23, 24, 30 None of the SNPs reported in these studies were significant (P > 0.001).
Discussion
This study suggests evidence for two new loci associated with two dimensions of personality: an intergenic region 135 kb downstream from RASA1 on 5q14.3 for Openness to Experience and the KATNAL2 gene region on 18q21.1 for Conscientiousness. However, these loci were not unequivocally replicated. The KATNAL2 gene was also significant in the genebased test. However, in the replication samples the effect did not reach a level of significance, although there was a consistency of direction of effects. Thus, KATNAL2 might present a novel gene for personality. It should be noted, however, that even if the signal represents a true finding, the effect size is small. No genome-wide significant results were found for Neuroticism, Extraversion and Agreeableness.
Power analyses showed that the genome-wide significant variants could not have been detected in any of the individual studies at the genome-wide significant level (power to detect these effects at a = 5 Â 10 À8 in sample sizes smaller than 4000 is less than 1%), but the power to detect these effects in the current meta-analytic study with a sample size of 17 375 is 77% for the top SNP for Openness to Experience and 72% for the top SNP of Conscientiousness. Additional power analyses showed that with a power of 80%, the meta-analysis could detect much smaller effect sizes than any of the individual studies (0.23% explained variance versus 1-6.5% explained variance for sample size of individual studies between 600 and 3972; explained variances correspond to standardized betas of 0.05 versus 0.1-0.25).
The findings of this study show that large-scale collaborative studies with combined sample sizes in the order of thousands or ten thousands still have difficulties in identifying common genetic variants that influence complex phenotypes such as personality traits. It could be that the effects of many SNPs are even smaller than the 0.2% that we were able to detect in this study at a genome-wide significance level. Larger GWA studies may reveal these variants, as has been already successfully shown for human height in a large meta-analytic GWA study of over 180 000 individuals, in which at least 180 loci were identified together explaining about 10% of the variation in height. 70 In addition, a recent paper using a novel technique to estimate the genetic variance explained by all SNPs, without focusing on genomewide significance of individual SNPs, showed that common SNP variation explained about half of the heritability of human height. 71 These papers are consistent with the notion that common SNP variation is important in explaining complex highly polygenic traits. It also suggests that the meta-analytic GWA study that we present here was only able to detect the top few SNPs with the largest effect sizes related to personality.
Many other explanations to explain the heritability of complex traits have been put forward. 72 One of these is that other variants that are currently not captured with the genome-wide SNP platforms (including copy number and rare variants) play a role in explaining variation in personality. Next-generation sequencing may reveal more genetic variants that account for the heritability of complex traits including personality. Nevertheless, identification of genetic variants, even if effect sizes are small, remains an important goal, because these variants can be critical entry points to increased understanding of the biological processes underlying personality as well as psychiatric disorders and other personality-related health, social and behavioral outcomes. 
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